Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents

Chemistry and Biology

Volumn 20, Issue 2, 2013, Pages 188-201

  Dalli, Jesmond ^a   Winkler, Jeremy W ^b   Colas, Romain A ^a   Arnardottir, Hildur ^a   Cheng, Chien Yee C ^a   Chiang, Nan ^a   Petasis, Nicos A ^b   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FATTY ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; HYDROXYL GROUP; INTERLEUKIN 10; INTERLEUKIN 6; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN D2; PROSTAGLANDIN E2; RESOLVIN D3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL POPULATION; CHIRALITY; DERMATITIS; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; STEREOCHEMISTRY; STEREOISOMERISM; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; ASPIRIN; CYTOKINES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MACROPHAGES; METABOLOME; MICE; NEUTROPHILS; PERITONITIS; PHAGOCYTOSIS; RECEPTORS, G-PROTEIN-COUPLED; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 84874302316     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.11.010     Document Type: Article

References (60)

1. G.L. Bannenberg, N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K.H. Gotlinger, S. Hong, and C.N. Serhan Molecular circuits of resolution: formation and actions of resolvins and protectins J. Immunol. 174 2005 4345 4355
2. A.F. Bento, R.F. Claudino, R.C. Dutra, R. Marcon, and J.B. Calixto Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice J. Immunol. 187 2011 1957 1969
3. H.R. Brady, and C.N. Serhan Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selectin Biochem. Biophys. Res. Commun. 186 1992 1307 1314
4. P.C. Calder Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2012 10.1111/j.1365-2125.2012.04374.x
5. N. Chiang, and C.N. Serhan Aspirin triggers formation of anti-inflammatory mediators: New mechanism for an old drug Discov. Med. 4 2004 470 475
6. 4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation J. Exp. Med. 191 2000 1197 1208
7. 4 and inhibits thromboxane in a randomized human trial Proc. Natl. Acad. Sci. USA 101 2004 15178 15183
8. 4 formation: a randomized human trial Arterioscler. Thromb. Vasc. Biol. 26 2006 e14 e17
9. N. Chiang, G. Fredman, F. Bäckhed, S.F. Oh, T.W. Vickery, B.A. Schmidt, and C.N. Serhan Infection regulates pro-resolving mediators that lower antibiotic requirements Nature 484 2012 524 528
10. J. Clària, and A. Planagumà Liver: the formation and actions of aspirin-triggered lipoxins Prostaglandins Leukot. Essent. Fatty Acids 73 2005 277 282
11. G. Coulthard, W. Erb, and V.K. Aggarwal Stereocontrolled organocatalytic synthesis of prostaglandin PGF2α in seven steps Nature 489 2012 278 281
12. J. Dalli, and C.N. Serhan Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators Blood 120 2012 e60 e72 10.1182/blood-2012-1104-423525
13. R. De Caterina n-3 fatty acids in cardiovascular disease N. Engl. J. Med. 364 2011 2439 2450
14. C.A. Dinarello Anti-inflammatory agents: present and future Cell 140 2010 935 950
15. M. Dona, G. Fredman, J.M. Schwab, N. Chiang, M. Arita, A. Goodarzi, G. Cheng, U.H. von Andrian, and C.N. Serhan Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets Blood 112 2008 848 855
16. J.S. Duffield, S. Hong, V.S. Vaidya, Y. Lu, G. Fredman, C.N. Serhan, and J.V. Bonventre Resolvin D series and protectin D1 mitigate acute kidney injury J. Immunol. 177 2006 5902 5911
17. D. El Kebir, P. Gjorstrup, and J.G. Filep Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation Proc. Natl. Acad. Sci. USA 109 2012 14983 14988
18. D.E. Furst, and J. Hillson Aspirin and other nonsteroidal antiinflammatory drugs W.J. Koopman, Arthritis and Allied Conditions: A Textbook of Rheumatology 2001 Lippincott Williams & Wilkins Philadelphia 665 716
19. S. Hong, Y. Lu, R. Yang, K.H. Gotlinger, N.A. Petasis, and C.N. Serhan Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms J. Am. Soc. Mass Spectrom. 18 2007 128 144
20. C.A. Hudert, K.H. Weylandt, Y. Lu, J. Wang, S. Hong, A. Dignass, C.N. Serhan, and J.X. Kang Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis Proc. Natl. Acad. Sci. USA 103 2006 11276 11281
21. Y. Isobe, M. Arita, S. Matsueda, R. Iwamoto, T. Fujihara, H. Nakanishi, R. Taguchi, K. Masuda, K. Sasaki, and D. Urabe Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid J. Biol. Chem. 287 2012 10525 10534
22. R.R. Ji, Z.Z. Xu, G. Strichartz, and C.N. Serhan Emerging roles of resolvins in the resolution of inflammation and pain Trends Neurosci. 34 2011 599 609
23. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.-H. Lee, R. Yang, N.A. Petasis, and C.N. Serhan Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc. Natl. Acad. Sci. USA 107 2010 1660 1665
24. S. Krishnamoorthy, A. Recchiuti, N. Chiang, G. Fredman, and C.N. Serhan Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs Am. J. Pathol. 180 2012 2018 2027
25. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
26. J.F. Lima-Garcia, R.C. Dutra, K. da Silva, E.M. Motta, M.M. Campos, and J.B. Calixto The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats Br. J. Pharmacol. 164 2011 278 293
27. N.A. Louis, K.E. Hamilton, and S.P. Colgan Lipid mediator networks and leukocyte transmigration Prostaglandins Leukot. Essent. Fatty Acids 73 2005 197 202
28. P. Maderna, and C. Godson Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells Prostaglandins Leukot. Essent. Fatty Acids 73 2005 179 187
29. G. Majno, R.S. Cotran, and N. Kaufman Current Topics in Inflammation and Infection 1982 Williams & Wilkins Baltimore
30. E. Mas, K.D. Croft, P. Zahra, A. Barden, and T.A. Mori Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation Clin. Chem. 58 2012 1476 1484 10.1373/clinchem.2012.190199
31. R. Medzhitov Inflammation 2010: new adventures of an old flame Cell 140 2010 771 776
32. T. Morris, M. Stables, A. Hobbs, P. de Souza, P. Colville-Nash, T. Warner, J. Newson, G. Bellingan, and D.W. Gilroy Effects of low-dose aspirin on acute inflammatory responses in humans J. Immunol. 183 2009 2089 2096
33. T. Morris, M. Stables, P. Colville-Nash, J. Newson, G. Bellingan, P.M. de Souza, and D.W. Gilroy Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways Proc. Natl. Acad. Sci. USA 107 2010 8842 8847
34. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
35. G.J. Patti, O. Yanes, L.P. Shriver, J.P. Courade, R. Tautenhahn, M. Manchester, and G. Siuzdak Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin Nat. Chem. Biol. 8 2012 232 234
36. N. Psychogios, D.D. Hau, J. Peng, A.C. Guo, R. Mandal, S. Bouatra, I. Sinelnikov, R. Krishnamurthy, R. Eisner, and B. Gautam The human serum metabolome PLoS ONE 6 2011 e16957
37. S.K. Raatz, M.Y. Golovko, S.A. Brose, T.A. Rosenberger, G.S. Burr, W.R. Wolters, and M.J. Picklo Sr. Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar) J. Agric. Food Chem. 59 2011 11278 11286
38. S. Ramon, F. Gao, C.N. Serhan, and R.P. Phipps Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells J. Immunol. 189 2012 1036 1042
39. A. Recchiuti, S. Krishnamoorthy, G. Fredman, N. Chiang, and C.N. Serhan MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits FASEB J. 25 2011 544 560
40. A.P. Rogerio, O. Haworth, R. Croze, S.F. Oh, M. Uddin, T. Carlo, M.A. Pfeffer, R. Priluck, C.N. Serhan, and B.D. Levy Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses J. Immunol. 189 2012 1983 1991
41. M. Romano Lipoxin and aspirin-triggered lipoxins ScientificWorldJournal 10 2010 1048 1064
42. B. Samuelsson From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures 1982 Almqvist & Wiksell Stockholm 153 174
43. B. Samuelsson Role of basic science in the development of new medicines: examples from the eicosanoid field J. Biol. Chem. 287 2012 10070 10080
44. C.N. Serhan Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways Annu. Rev. Immunol. 25 2007 101 137
45. C.N. Serhan The resolution of inflammation: the devil in the flask and in the details FASEB J. 25 2011 1441 1448
46. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat. Immunol. 6 2005 1191 1197
47. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem. Rev. 111 2011 5922 5943
48. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
49. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.-L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
50. T. Shimizu Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation Annu. Rev. Pharmacol. Toxicol. 49 2009 123 150
51. M. Spite, L.V. Norling, L. Summers, R. Yang, D. Cooper, N.A. Petasis, R.J. Flower, M. Perretti, and C.N. Serhan Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
52. M.J. Stables, S. Shah, E.B. Camon, R.C. Lovering, J. Newson, J. Bystrom, S. Farrow, and D.W. Gilroy Transcriptomic analyses of murine resolution-phase macrophages Blood 118 2011 e192 e208
53. Y.-P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S.P. Colgan, N.A. Petasis, and C.N. Serhan Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J. Biol. Chem. 282 2007 9323 9334
54. A.I. Tauber, and L. Chernyak Metchnikoff and the Origins of Immunology: From Metaphor to Theory 1991 Oxford University Press New York
55. E. Titos, B. Rius, A. González-Périz, C. López-Vicario, E. Morán-Salvador, M. Martínez-Clemente, V. Arroyo, and J. Clària Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype J. Immunol. 187 2011 5408 5418
56. J.R. Vane Adventures and excursions in bioassay: the stepping stones to prostacyclin Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures 1982 Almqvist & Wiksell Stockholm 181 206
57. J. von Moltke, N.J. Trinidad, M. Moayeri, A.F. Kintzer, S.B. Wang, N. van Rooijen, C.R. Brown, B.A. Krantz, S.H. Leppla, K. Gronert, and R.E. Vance Rapid induction of inflammatory lipid mediators by the inflammasome in vivo Nature 490 2012 107 111 10.1038/nature11351
58. K.A. Weldon, and J. Whelan Allometric scaling of dietary linoleic acid on changes in tissue arachidonic acid using human equivalent diets in mice Nutr. Metab. (Lond) 8 2011 43
59. S.H. Wu, X.Q. Chen, B. Liu, H.J. Wu, and L. Dong Efficacy and Safety of 15(R/S)-Methyl-Lipoxin A(4) in Topical Treatment of Infantile Eczema Br. J. Dermatol. 2012 10.1111/j.1365-2133.2012.11177.x
60. Z.-Z. Xu, L. Zhang, T. Liu, J.-Y. Park, T. Berta, R. Yang, C.N. Serhan, and R.-R. Ji Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions Nat. Med. 16 2010 592 597 1p, 597